Pregnant Women Injected With Banned, Blacklisted Pharma Company’s Shot; Five Women Lose Memory And..

In a shocking incident in Gujarat, five pregnant women reportedly lost their memory after receiving injections from a blacklisted pharmaceutical company. The case of gross negligence occurred at Sanjay Gandhi Medical College in Rewa. According to reports, the women were administered a medicine that had already been banned and blacklisted. Following the injection, all five women began exhibiting symptoms of memory loss. An initial investigation suggests the injection was mistakenly issued by the hospital’s storekeeper.

The First Complaint Came From Vidisha

A complaint regarding this injection was first received from Vidisha Medical College in October 2024, after which the medicine was banned. Gujarat-based Radiant Parenterals Limited company was officially blacklisted following the report in December. Reports suggests that the pharmacist had issued the banned medicine, and appropriate action has been taken against him.

Gujarat-based Radiant Parenterals Limited

The storekeeper has been suspended in connection with the incident, but no action has been taken against other officials so far. Due to this negligence, the pharmaceutical company has also been fined and blacklisted. The incident occurred at Sanjay Gandhi Medical College in Rewa.

What Happened At Sanjay Gandhi Medical College

At Sanjay Gandhi Medical College in Rewa, five pregnant women were administered an anesthesia injection manufactured by Gujarat-based Radiant Parenterals Limited. The company had already been blacklisted in December due to poor quality standards of its injections.

Banned Injection Issued By Storekeeper

The investigation revealed that hospital storekeeper Praveen Upadhyay mistakenly issued the banned injection, leading to his suspension. However, despite the gravity of the incident, no action was taken against other responsible officials. The probe also uncovered serious lapses in medicine storage—temperature was not properly monitored, inventory records were poorly maintained, and expired or substandard drugs were stored alongside approved ones.

Gujarat-based Radiant Parenterals Limited Banned For 5 Years

The company has been debarred from undertaking any government contracts for five years and blacklisted for two years. Additionally, a fine of ₹3.01 lakh has been imposed on the company. The use of the injection produced by Radiant Parenterals Limited was banned.

Related Posts

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

New Delhi: AstraZeneca’s India-arm has partnered with National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, to build clinical research capabilities at 25 emerging geographies in a bid to extend…

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Following a bumpy regulatory road that involved a refusal-to-file, ImmunityBio has won FDA approval to expand Anktiva into papillary-only non-muscle-invasive bladder cancer (NMIBC). Wednesday’s approval comes nearly three months ahead…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction